logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Soo Lim

yonsei university health system
H指数:69
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Guideline on treatment intensification with injectable therapies beyond GLP-1 RA based therapies in type 2 diabetes

2型糖尿病中基于GLP-1 RA以外注射疗法强化治疗的指南

Diabetes Research and Clinical Practice
IF7.4
2026-08-020
PRE
Yingying Luo; Jun Xia; Xiaomei Yao; Seyed Adel; Yong Mong Bee; Liming Chen; Siew Pheng Chan; Chaicharn Deerochanawong; Alice Pik Shan Kong; Khue Thy Nguyen; Xiaoying Li; Soo Lim; Navin Kumar Loganadan; Margaret McGill; Selva Elizabeth Trejo; Daisuke Yabe; Li Yan; Peipei Li; Zhan Zhao; Shihui Chen
Efficacy and Safety of Fixed-Dose Combinations of Sitagliptin and Empagliflozin as Add-On to Metformin in Korean Patients With Type 2 Diabetes: A Randomised, Double-Blind, Multi-Centre, Placebo-Controlled, Phase III Trial

西格列汀和恩格列净固定剂量组合作为二甲双胍的加用药物在韩国2型糖尿病患者中的疗效与安全性：一项随机、双盲、多中心、安慰剂对照、III期试验

diabetes, obesity and metabolism
IF0
2026-03-260
OAAI
Soo Lim; Tae Nyun Kim; Ji Oh Mok; Choon Hee Chung; You Cheol Hwang; Ho Chan Cho; Jong Chul Won; Eonju Jeon; Eun Seok Kang; Ki Young Lee; Chong Hwa Kim; Soo Heon Kwak; Cheol Young Park; Kang Seo Park; Sang Yong Kim; Jae Hyuk Lee; Soon Hee Lee; Dong Hyeok Cho; Hyuk-Sang Kwon; Kyung Ah Han
Utility of continuous glucose monitoring in people with type 2 diabetes on insulin-based regimens in clinical practice: A case series and expert opinion

连续血糖监测在临床实践中接受胰岛素治疗方案2型糖尿病患者中的应用价值：病例系列研究和专家意见

Diabetes Research and Clinical Practice
IF7.4
2025-12-130
PRE
Soo Lim; Rimei Nishimura; Jothydev Kesavadev; Alice Pik Shan Kong; Margaret J McGill; Horng-Yih Ou; Chun-Kwan O; Chun-Chuan Lee; Xiaomei Zhang; Linong Ji; Chih-Yuan Wang
Efficacy and safety in tirzepatide-treated Korean adults with type 2 diabetes—A post hoc analysis of SURPASS-AP-combo and SURPASS-3

Tirzepatide治疗韩国2型糖尿病成人患者的有效性与安全性——SURPASS-AP-combo和SURPASS-3的后续分析

diabetes obesity metabolism
IF0
2025-09-150
OAAI
Byung Wan Lee MD; Chang Beom Lee MD; Soo Lim MD; Sin Gon Kim MD; Nan Hee Kim MD; Jong Chul Won MD; Woo Je Lee MD; Min Ju Kang MD; Ju Young Yuh BS; Li Ying Du MS; Hyojin Lim PhD; Kyu Jeung Ahn MD
Once-weekly semaglutide 2·4 mg in an Asian population with obesity, defined as BMI ≥25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial

在韩国和泰国亚洲肥胖人群中每周一次使用2.4 mg司美格鲁肽（BMI ≥25 kg/m²）（STEP 11）：一项随机、双盲、安慰剂对照的3期临床试验

The Lancet Diabetes & Endocrinology
IF0
2025-08-150
PRE
Soo Lim; Supawan Buranapin; Xiaolei Bao; María Quiroga; Kyung Hee Park; Jee-Hyun Kang; Anders Rasmussen Rinnov; Arisara Suwanagool

研究方向

暂未获取到该数据
H
Hak Chul Jang
H 指数:70论文数:463被引数:2.6万
S
Sung Hee Choi
H 指数:60论文数:475被引数:1.4万
K
Kyong Soo Park
H 指数:100论文数:929被引数:5.4万
K
Kyoung Min Kim
H 指数:42论文数:228被引数:6,150
J
Jae Hoon Moon
H 指数:39论文数:178被引数:4,616
Y
Young Joo Park
H 指数:74论文数:1,484被引数:2.1万
K
Ki Woong Kim
H 指数:76论文数:887被引数:2.3万
J
Ji Won Yoon
H 指数:36论文数:145被引数:5,021
T
Tae Jung Oh
H 指数:32论文数:186被引数:4,324
S
Seon Mee Kang
H 指数:25论文数:53被引数:3,090